These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34820449)

  • 1. Treatment of severe
    Zweijpfenning SMH; Kops SEP; Boeree MJ; Kuipers S; van Ingen J; Hoefsloot W; Magis-Escurra C
    ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34820449
    [No Abstract]   [Full Text] [Related]  

  • 2. A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the
    Lee JM; Park J; Choi S; Jhun BW; Kim SY; Jo KW; Hong JJ; Kim LH; Shin SJ
    Front Microbiol; 2020; 11():626216. PubMed ID: 33519787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Brode SK; Chung H; Campitelli MA; Kwong JC; Marchand-Austin A; Winthrop KL; Jamieson FB; Marras TK
    Emerg Infect Dis; 2019 Jul; 25(7):1271-80. PubMed ID: 31215507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine.
    Field SK; Cowie RL
    Chest; 2003 Oct; 124(4):1482-6. PubMed ID: 14555583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
    Jarand J; Davis JP; Cowie RL; Field SK; Fisher DA
    Chest; 2016 May; 149(5):1285-93. PubMed ID: 26513209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
    Rastogi N; Goh KS; Bryskier A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory
    Kim BG; Kim H; Kwon OJ; Huh HJ; Lee NY; Baek SY; Sohn I; Jhun BW
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32937940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcomes of Clofazimine-Containing Regimens in Severe
    Lee I; Hwang EJ; Kim JY; Yim JJ; Kwak N
    Open Forum Infect Dis; 2024 Feb; 11(2):ofad682. PubMed ID: 38328494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of
    Kwon YS; Koh WJ; Daley CL
    Tuberc Respir Dis (Seoul); 2019 Jan; 82(1):15-26. PubMed ID: 30574687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
    Kim HJ; Lee JS; Kwak N; Cho J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2019 Nov; 19(1):212. PubMed ID: 31711459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
    Daley CL; Winthrop KL
    J Infect Dis; 2020 Aug; 222(Suppl 4):S199-S211. PubMed ID: 32814943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
    Benson CA; Kessler HA; Pottage JC; Trenholme GM
    Arch Intern Med; 1991 Mar; 151(3):582-5. PubMed ID: 2001140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
    Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
    Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
    AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.